Tumour-infiltrating lymphocytes in advanced HER2-positive breast cancer treated with pertuzumab or placebo in addition to trastuzumab and docetaxel: a retrospective analysis of the CLEOPATRA study

Tumour infiltrating lymphocytes and stromal CD68 in early stage HER2 positive breast cancer

Journal of Clinical Pathology ◽

10.1136/jclinpath-2015-203493 ◽

2016 ◽

Vol 69 (6) ◽

pp. 552-555 ◽

Cited By ~ 3

Author(s):

Jacques Raphael ◽

IY Gong ◽

S Nofech-Mozes ◽

JMS Bartlett ◽

H Nafisi ◽

...

Keyword(s):

Breast Cancer ◽

Early Stage ◽

Her2 Positive ◽

Prognostic value of tumour-infiltrating lymphocytes in small HER2-positive breast cancer

European Journal of Cancer ◽

10.1016/j.ejca.2017.10.011 ◽

2017 ◽

Vol 87 ◽

pp. 164-171 ◽

Cited By ~ 3

Author(s):

Carmen Criscitiello ◽

Vincenzo Bagnardi ◽

Giancarlo Pruneri ◽

Andrea Vingiani ◽

Angela Esposito ◽

...

Keyword(s):

Breast Cancer ◽

Prognostic Value ◽

Her2 Positive ◽

Prognostic and predictive role of spatially positioned tumour infiltrating lymphocytes in metastatic HER2 positive breast cancer treated with trastuzumab

Scientific Reports ◽

10.1038/s41598-017-18266-1 ◽

2017 ◽

Vol 7 (1) ◽

Cited By ~ 6

Author(s):

Tiia J. Honkanen ◽

Tiina Moilanen ◽

Peeter Karihtala ◽

Satu Tiainen ◽

Päivi Auvinen ◽

...

Keyword(s):

Breast Cancer ◽

Her2 Positive ◽

Predictive Role ◽

Programmed death-ligand 1 (PD-L1) expression in tumour cell and tumour infiltrating lymphocytes of HER2-positive breast cancer and its prognostic value

Scientific Reports ◽

10.1038/s41598-017-11905-7 ◽

2017 ◽

Vol 7 (1) ◽

Cited By ~ 30

Author(s):

Ahrong Kim ◽

So Jeong Lee ◽

Young Keum Kim ◽

Won Young Park ◽

Do Youn Park ◽

...

Keyword(s):

Breast Cancer ◽

Tumour Cell ◽

Prognostic Value ◽

Her2 Positive ◽

Programmed Death Ligand 1 ◽

Programmed Death ◽

Optimal threshold for stromal tumor-infiltrating lymphocytes: its predictive and prognostic value in HER2-positive breast cancer treated with trastuzumab-based neoadjuvant chemotherapy

Breast Cancer Research and Treatment ◽

10.1007/s10549-015-3617-7 ◽

2015 ◽

Vol 154 (2) ◽

pp. 239-249 ◽

Cited By ~ 13

Author(s):

Shiwei Liu ◽

Xuening Duan ◽

Ling Xu ◽

Ling Xin ◽

Yuanjia Cheng ◽

...

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Prognostic Value ◽

Optimal Threshold ◽

Her2 Positive ◽

Predictive And Prognostic Value ◽

Pathological Complete Response with Neoadjuvant Trastuzumab Combined with Chemotherapy in HER2 Positive Breast Cancer: A Single Institution Retrospective Analysis from Vietnam

Breast Cancer Targets and Therapy ◽

10.2147/bctt.s268369 ◽

2020 ◽

Vol Volume 12 ◽

pp. 117-122

Author(s):

Huyen Thi Phung ◽

Hoa Thi Nguyen ◽

Tung Van Nguyen ◽

Tai Van Nguyen ◽

Lan Anh Thi Dinh ◽

...

Keyword(s):

Breast Cancer ◽

Retrospective Analysis ◽

Pathological Complete Response ◽

Complete Response ◽

Single Institution ◽

Her2 Positive ◽

FcrR3A-158 Polymorphism and Stromal Tumor-Infiltrating Lymphocytes and Survival among Patients with Metastatic HER2-Positive Breast Cancer Receiving Trastuzumab-Based Treatment

Journal of Breast Cancer ◽

10.4048/jbc.2018.21.1.45 ◽

2018 ◽

Vol 21 (1) ◽

pp. 45

Author(s):

Heejung Chae ◽

Changhoon Yoo ◽

Jung-A Yoon ◽

Hee Jin Lee ◽

Kyu-pyo Kim ◽

...

Keyword(s):

Breast Cancer ◽

Stromal Tumor ◽

Her2 Positive ◽

Abstract P6-16-08: Prognostic factor of HER2-positive breast cancer patients developed brain metastasis: A multicenter retrospective analysis

10.1158/1538-7445.sabcs14-p6-16-08 ◽

2015 ◽

Author(s):

Naoki Hayashi ◽

Naoki Niikura ◽

Norikazu Masuda ◽

Seiki Takashima ◽

Rikiya Nakamura ◽

...

Keyword(s):

Breast Cancer ◽

Prognostic Factor ◽

Brain Metastasis ◽

Retrospective Analysis ◽

Cancer Patients ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Abstract P6-09-07: Mutation characteristics and tumor infiltrating lymphocytes in early and metastatic HER2-positive breast cancer

10.1158/1538-7445.sabcs16-p6-09-07 ◽

2017 ◽

Author(s):

V Kotoula ◽

E Giannoulatou ◽

G Kouvatseas ◽

I Tikas ◽

G Lazaridis ◽

...

Keyword(s):

Breast Cancer ◽

Her2 Positive ◽

Abstract P4-14-17: Prognostic value of tumor-infiltrating lymphocytes in residual tumors after neoadjuvant chemotherapy concomitant with trastuzumab for HER2-positive breast cancer

10.1158/1538-7445.sabcs15-p4-14-17 ◽

2016 ◽

Author(s):

S Kurozumi ◽

K Inoue ◽

H Matsumoto ◽

Y Hayashi ◽

K Tozuka ◽

...

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Prognostic Value ◽

Her2 Positive ◽